ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Order Full text via Infotrieve
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davies, B.
Right arrow Articles by Maesen, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davies, B.
Right arrow Articles by Maesen, F.
Eur Respir J 1988; 1: 415-420
Copyright © ERS Journals Ltd 1988


Original Articles

The epidemiology of respiratory tract pathogens in southern Netherlands

BI Davies and FP Maesen

Results of sputum cultures and susceptibility tests have been reviewed for the years 1977-1986, with approximately 1,700 positive cultures per year. Haemophilus influenzae always occupied the first place, being grown in 65% of positive specimens in 1977 and 37% in 1986. Streptococcus pneumoniae occupied the second place, rising from 17 to 27% in the same period, during which Branhamella catarrhalis rose from 5 to 26%. Based on the frequency of occurrence of individual bacterial species in the sputum cultures and on the percentage of strains resistant to ampicillin, cotrimoxazole, doxycycline, erythromycin and ofloxacin, theoretical chances of failure of blind therapy were calculated and found to be most advantageous for ofloxacin and cotrimoxazole. No explanation could be given for the increase in beta-lactamase production by B. catarrhalis, but the disappearance of Haemophilus parainfluenzae may have been due to improvements in the identification procedure.


This article has been cited by other articles:


Home page
Clin. Microbiol. Rev.Home page
C. M. Verduin, C. Hol, A. Fleer, H. van Dijk, and A. van Belkum
Moraxella catarrhalis: from Emerging to Established Pathogen
Clin. Microbiol. Rev., January 1, 2002; 15(1): 125 - 144.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. C. McMichael, M. J. Fiske, R. A. Fredenburg, D. N. Chakravarti, K. R. VanDerMeid, V. Barniak, J. Caplan, E. Bortell, S. Baker, R. Arumugham, et al.
Isolation and Characterization of Two Proteins from Moraxella catarrhalis That Bear a Common Epitope
Infect. Immun., September 1, 1998; 66(9): 4374 - 4381.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. Aebi, E. R. Lafontaine, L. D. Cope, J. L. Latimer, S. L. Lumbley, G. H. McCracken Jr., and E. J. Hansen
Phenotypic Effect of Isogenic uspA1 and uspA2 Mutations on Moraxella catarrhalis 035E
Infect. Immun., July 1, 1998; 66(7): 3113 - 3119.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. Aebi, L. D. Cope, J. L. Latimer, S. E. Thomas, C. A. Slaughter, G. H. McCracken Jr., and E. J. Hansen
Mapping of a Protective Epitope of the CopB Outer Membrane Protein of Moraxella catarrhalis
Infect. Immun., February 1, 1998; 66(2): 540 - 548.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the European Respiratory Society.